Small Molecule Therapeutic Approaches With a Greater Focus on Hearing Loss: A Review
Health Science Reports · 2026-10 · 9 (10)
DOI: 10.1002/hsr2.73323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 10.10.2026. Verfasst von Maryam Naghinejad und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Faculty of Medicine Tabriz University of Medical Sciences Tabriz Iran. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Aims Hearing loss (HL) is one of the most common sensory impairments worldwide and has substantial effects on quality of life and daily functioning. Although cochlear implants and hearing aids have markedly improved the management of hearing impairment, these devices do not directly address the underlying pathogenic mechanisms of HL. This review aims to summarize the pathophysiology and classification of HL and to discuss the potential therapeutic applications of small molecules (SMs) in its management.
Methods
This review focuses on the major pathological mechanisms involved in different forms of HL and summarizes preclinical and clinically relevant SM‐based therapeutic approaches. The reviewed strategies include pharmacological chaperones, transcriptional modulation, ion‐channel modulators, neuroprotective compounds, apoptosis inhibitors, and regenerative approaches.
Results
SMs possess physicochemical properties that make them suitable for targeting specific molecular pathways involved in HL. Current evidence suggests that SM‐based interventions may act through diverse mechanisms, including attenuation of oxidative stress, inflammation, and apoptosis; modulation of ion channels; support of auditory neuron survival and function; and promotion of regenerative signaling.
Conclusion
SM‐based therapeutic approaches represent promising strategies for addressing the molecular and cellular mechanisms underlying HL. These approaches may provide valuable directions for future research and support the development of targeted therapies for individuals with hearing impairment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Genetics, Faculty of Medicine Tabriz University of Medical Sciences Tabriz Iran.
- Student Research Committee Golestan University of Medical Sciences Gorgan Iran.
- Department of Medical Genetics, Faculty of Advanced Technologies in Medicine Golestan University of Medical Science Gorgan Iran.
- Student Research Committee Tabriz University of Medical Sciences Tabriz Iran.
- Department of Molecular Medicine, Faculty of Advanced Medical Sciences Tabriz University of Medical Sciences Tabriz Iran.
ORCID-Profile: Maryam Naghinejad, Farzaneh Motallebi, Elaheh Hasani, Moein Kohkalani, Sepideh Parvizpour, Sima Mansoori Derakhshan
Zitieren
APA
Naghinejad, M., Motallebi, F., Hasani, E., Kohkalani, M., Parvizpour, S., & Mansoori Derakhshan, S. (2026). Small Molecule Therapeutic Approaches With a Greater Focus on Hearing Loss: A Review. Health Science Reports, 9(10). https://doi.org/10.1002/hsr2.73323
Vancouver
Naghinejad M, Motallebi F, Hasani E, Kohkalani M, Parvizpour S, Mansoori Derakhshan S. Small Molecule Therapeutic Approaches With a Greater Focus on Hearing Loss: A Review. Health Science Reports. 2026;9(10). doi:10.1002/hsr2.73323
BibTeX
@article{Naghinejad2026,
author = {Naghinejad, Maryam and Motallebi, Farzaneh and Hasani, Elaheh and Kohkalani, Moein and Parvizpour, Sepideh and Mansoori Derakhshan, Sima},
title = {Small Molecule Therapeutic Approaches With a Greater Focus on Hearing Loss: A Review},
journal = {Health Science Reports},
year = {2026},
volume = {9},
number = {10},
doi = {10.1002/hsr2.73323}
}
EUVIMED